Insight

Jun 9, 2024, 16:20

Sheheryar Kabraji: Look at how ER low tumors behave

Sheheryar Kabraji, Associate Professor at

“! Very cool story re-examining how to combine endocrine and chemotherapy in ER+ breast cancer with cool use of the MPI index.

Look at how ER low tumors behave!

Congrats Albert Grinshpun, RM Jesel, Sandro Santagata, Dana-Farber Cancer Institute and Harvard Program in Therapeutic Science.”

Visit the article website.
Source: Sheheryar Kabraji/X

Albert Grinshpun cancer chemotherapy Dana-Farber Cancer Institute ER-low tumors ER+ breast cancer Harvard Program in Therapeutic Science MPI index OncoDaily Oncology RM Jesel Roswell Park Comprehensive Cancer Center Sandro Santagata Sheheryar Kabraji

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity